Publications

Foundation-Model Imaging Biomarkers for Pancreatic Cancer: Cross-Species Discovery of Conserved Tumour Biology in Mouse MRI and Human CT

Yu G, et al.

eBioMedicine

Frozen foundation-model embeddings recover matched biological endpoints from both mouse 9.4T MRI and human clinical CT, outperforming hand-crafted radiomics, end-to-end fine-tuning, and a purpose-built 3D-CT vision-language model.

A Systematic Review of Reward Design and Evaluation in Reinforcement-Learning Post-Training of Medical Imaging Models

Yu G, et al.

npj Digital Medicine

Multi-Task Deep Learning on MRI for Tumor Segmentation and Treatment Response Prediction in an Experimental Model of Hepatocellular Carcinoma

Yu G, Zhang Z, Eresen A, Hou Q, Yaghmai V, Zhang Z.

Diagnostics 15(22):2844

U-Net++ with an EfficientNet-B0 encoder segments the tumor and predicts response in one pass, reaching Dice 0.92 and AUROC 0.97, with the imaging biomarkers validated against H&E viability and TUNEL apoptosis.

Code

AI-Derived MRI Biomarkers Using Vision Transformer for Predicting Combination Immunotherapy Outcomes in Liver Cancer

Yu G, et al.

ISMRM & ISMRT Annual Meeting

Combination of Irreversible Electroporation and Clostridium novyi-NT Bacterial Therapy for Colorectal Liver Metastasis

Zhang Z, Yu G, Hou Q, et al.

Cancers 17(15):2477

Therapy Combining Sorafenib and Natural Killer Cells for Hepatocellular Carcinoma: Insights from Magnetic Resonance Imaging and Histological Analyses

Zhang Z, Yu G, et al.

Cancers 17(4):699

MRI radiomics to monitor therapeutic outcome of sorafenib plus IHA transcatheter NK cell combination therapy in hepatocellular carcinoma

Yu G, et al.

Journal of Translational Medicine 22(1):76

743 radiomic features reduced to five. An SVM on T1w and T2w reaches AUC 1.00 for binary response and 0.93 across outcome classes, with MRI-derived measures tracking histology at r = 0.94.

Predicting and Monitoring Immune Checkpoint Inhibitor Therapy Using Artificial Intelligence in Pancreatic Cancer

Yu G, Zhang Z, Eresen A, et al.

International Journal of Molecular Sciences 25(22):12038

Sorafenib plus memory-like natural killer cell immunochemotherapy boosts treatment response in liver cancer

Eresen A, Zhang Z, Yu G, et al.

BMC Cancer 24:1215

Sorafenib plus memory like natural killer cell combination therapy in hepatocellular carcinoma

Eresen A, Zhang Z, Yu G, et al.

American Journal of Cancer Research 14(1):344–354

MRI monitoring of combined therapy with transcatheter arterial delivery of NK cells and systemic administration of sorafenib

Zhang Z, Yu G, et al.

American Journal of Cancer Research 14(5):2216–2227

Dendritic cell vaccination combined with irreversible electroporation for treating pancreatic cancer, a narrative review

Zhang Z, Yu G, et al.

Annals of Translational Medicine 12(4):77

Qtrade AI at SemEval-2022 Task 11: An Unified Framework for Multilingual NER Task

Gan W, Lin Y, Yu G, et al.  Co-first author

Proceedings of SemEval-2022, ACL

An XLM-RoBERTa system with continued pretraining, adversarial training, and ensembling. Third in the multilingual track, fourth in code-mixed, seventh in Chinese.